OSIRIS THERAPEUTICS INC NEW - COM (OSIR)

CUSIP: 68827R108

Q4 2014 13F Holders as of 31 Dec 2014

Type / Class
Equity / COM
Total 13F shares
8,477,785
Share change
-204,996
Total reported value
$135,558,280
Put/Call ratio
1853%
Price per share
$15.99
Number of holders
65
Value change
-$1,026,822
Number of buys
30
Number of sells
24

Quarterly Holders Quick Answers

What is CUSIP 68827R108?
CUSIP 68827R108 identifies OSIR - OSIRIS THERAPEUTICS INC NEW - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of OSIRIS THERAPEUTICS INC NEW - COM (OSIR) as of Q4 2014

As of 31 Dec 2014, OSIRIS THERAPEUTICS INC NEW - COM (OSIR) was held by 65 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 8,477,785 shares. The largest 10 holders included FMR LLC, Consonance Capital Management LP, BlackRock Fund Advisors, BlackRock Institutional Trust Company, N.A., VANGUARD GROUP INC, BAKER BROS. ADVISORS LP, State Street Corp, NORTHERN TRUST CORP, SUSQUEHANNA INTERNATIONAL GROUP, LLP, and GEODE CAPITAL MANAGEMENT, LLC. This page lists 65 institutional shareholders reporting positions in this security for the Q4 2014 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.